申请人:John Wyeth & Brother, Ltd.
公开号:US05627177A1
公开(公告)日:1997-05-06
Piperazine derivatives of formula (I) and their pharmaceutically acceptable salts are 5-HT.sub.1A binding agents and may be used, for example, as anxiolytics. In the formula, A is an optionally substituted alkylene chain, Z is a specified bicyclic nitrogen containing heteroaromatic radical, R is hydrogen or lower alkyl, R.sup.1 is aryl or aryl(lower)alkyl and R.sup.2 and R.sup.3 are hydrogen or specified organic radicals or --NR.sup.2 R.sup.3 represents a heterocyclic ring. ##STR1##
公式(I)的哌嗪衍生物及其药学上可接受的盐是5-HT.sub.1A结合剂,例如可用作抗焦虑药。在该公式中,A是可选择地取代的烷基链,Z是指定的含氮杂环芳基,R是氢或较低的烷基,R.sup.1是芳基或芳基(较低)烷基,R.sup.2和R.sup.3是氢或指定的有机基团,或--NR.sup.2 R.sup.3代表一个杂环环。